MRD Study protocol is the immunotherapy that can be combined with a standard chemotherapy drug, potentially achieving better clinical outcomes than traditional treatment for individuals battling ovarian cancer.
To help the body’s immune system fight cancer cells, MRD Study induces a potent anti-cancer immunity protein at the cancer site.